Pamiparib is a potent and selective oral PARPi not affected by P-gp efflux pump • Mass spectrometry imaging to study pamiparib in tumor overexpressing P-gp • Multimodal imaging approach in quantitatively measuring drug distribution spatially
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging
Giuseppe Martano;
2024
Abstract
Pamiparib is a potent and selective oral PARPi not affected by P-gp efflux pump • Mass spectrometry imaging to study pamiparib in tumor overexpressing P-gp • Multimodal imaging approach in quantitatively measuring drug distribution spatiallyFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S209517792400176X-main.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
3.33 MB
Formato
Adobe PDF
|
3.33 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
